Independent. No tobacco money. No corporate fluff.TUE, AUG 18

PouchDaily

The daily pulse of the nicotine pouch market

MarketUS · GB

Pouches make 8× the unit profit of cigarettes — Big Tobacco notices

A Reuters analysis reveals PMI's U.S. nicotine pouch business generates 8 times the gross profit per thousand units of its international cigarette business. BAT forecasts the pouch market reaching £11 billion by 2030 — overtaking vapes. But can the category travel beyond Scandinavia and the U.S.?

PouchDaily Desk·

Nicotine pouches don't just sell fast. They are now the most profitable product per unit in Big Tobacco's portfolio — and the industry knows it.

A Reuters analysis published on 18 August 2026 laid out the strategic case in stark financial terms. Philip Morris International said last year that its U.S. pouch business generated eight times the gross profit per thousand units of its international cigarette business in 2024. For comparison, IQOS — PMI's flagship heated tobacco device — generated 2.4 times as much gross profit per thousand units as cigarettes.

That margin gap explains why investors and executives are repositioning pouches from a side category to the central growth engine. "I do believe that this is an engine of growth … that has the potential to replace cigarettes in the long run," BAT Chief Executive Tadeu Marroco told Reuters.

The £11 billion forecast

BAT predicts industry-wide pouch revenue will reach £11 billion ($15 billion) by 2030, overtaking the vape category, up from £4 billion in 2025. The company expects 47 million pouch users by then — just over half the projected number of vape users.

These are company-published forecasts, not independent analyst consensus. But they align with the direction of travel visible in reported results: BAT's Modern Oral revenue rose 65.9% in the first half of 2026, and PMI's smoke-free products now account for roughly 42% of total net revenues.

The category is also growing faster than vapes and heated tobacco, Reuters reported, drawing investor attention at a time when broader consumer goods demand is subdued.

Why pouches beat cigarettes on margin

Several factors explain the profit advantage:

  • No combustion, no tobacco leaf. Pouches contain synthetic or extracted nicotine, plant fibres and flavourings — cheaper raw materials than processed tobacco.
  • Lower regulatory friction (for now). In most of the world, pouches face fewer restrictions than cigarettes, vapes or heated tobacco. The WHO said in May that 160 countries still have no specific pouch regulation.
  • Dominant market positions. Unlike vaping, where Chinese manufacturers control much of the hardware market, PMI and BAT dominate pouch sales. That concentration means higher pricing power.
  • Discreet use. Pouches produce no smoke or vapour, allowing use where other nicotine products are restricted. That expands consumption occasions.

Jefferies analyst Andrei Andon-Ionita told Reuters that tobacco company valuations are "increasingly linked to pouch performance" — a sign that Wall Street now treats pouches as a core metric, not a footnote.

The volume reality check

The profit numbers are striking, but the volume picture is more sobering. At PMI, oral nicotine products account for just 2.6% of total volumes. Cigarettes remain the industry's profit engine, and when an unexpected increase in cigarette sales helped PMI beat Q2 expectations, Bernstein analysts noted that investor focus on Zyn had "obscured the continued importance of the company's traditional business."

BAT's pouch volumes tell a similar story of growth from a small base. Volumes across Asia, the Middle East and Africa rose 27.5% to around 700 million pouches in the first half of 2026 — strong growth, but still a fraction of the more than 3 billion pouches sold in its U.S. and European businesses.

The adoption hurdle

The central question for investors, Reuters reported, is whether pouches can match the popularity of other nicotine products in markets without an established oral nicotine tradition.

"Consumers in many countries may be more comfortable inhaling nicotine than consuming it orally," said Quilter Cheviot analyst Chris Beckett. Jefferies' Andon-Ionita called the lack of an oral nicotine culture outside a handful of markets the "biggest obstacle to wider adoption."

That means the £11 billion forecast depends on a behavioural shift that hasn't happened yet — persuading smokers in non-Scandinavian, non-U.S. markets to put a pouch under their lip instead of lighting up.

What tighter regulation could change

The WHO has called for tighter controls on pouches, citing youth uptake and aggressive marketing. France has banned pouches outright. Finland has introduced restrictions including plain packaging. Britain and the EU are tightening rules.

Both BAT and PMI told Reuters they "encourage appropriate regulation." But tighter rules — flavour bans, advertising restrictions, nicotine caps — could slow the growth trajectory that underpins the 2030 forecasts.

For now, the margin advantage and growth rates are real and documented. Whether they translate into pouches genuinely replacing cigarettes as the industry's profit engine depends on two things Big Tobacco cannot fully control: consumer habits in markets without a snus tradition, and regulators who may not share the industry's timeline.

Compare nicotine pouch brands and prices at PouchFinder.

SOURCES: